ROBERT DISCORDIA

Company: Equulus Therapeutics

Job title: CEO

Seminars:

Grounding the Excitement of Psychedelics: Developing Non-Hallucinogenic Compounds That Are Commercially Viable 12:30 pm

Developing therapeutics that will be embraced by mainstream payers and realistically adopted by pharmaceutical companies Considerations for patient adoption: eliminating the psychotropic acute phase of their dosingRead more

day: Track 2 AM Day 2